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a b s t r a c t 
Hypromellose acetate succinate (HPMCAS) microparticles containing the poorly-water sol- 
uble drug celecoxib (CEL) were prepared by electrospraying intended for oral drug delivery. 
Various solvent mixtures with different solubility for CEL and HPMCAS were used to induce 
changes in the polymer structural conformation of the microparticles. The performance of 
the prepared microparticles was evaluated by studying the solid state from, particle size 
and morphology, radial drug distribution and drug release. CEL was amorphous in all elec- 
trosprayed HPMCAS microparticles. The particle size and morphology was dependent on the 
solubility of HPMCAS in the solvent mixture used with poorer solvents resulting in smaller 
microparticles with rougher appearance. The CEL distribution on the particles surface was 
relatively homogeneous and similar for all microparticles. Drug release from the micropar- 
ticles was observed at a higher rate depending on the solubility of HPMCAS in the solvent 
used for electrospraying, and in all cases an at least 4-fold higher rate was observed com- 
pared with the crystalline drug. Drug precipitation from the supersaturated solution was 
inhibited by HPMCAS for all microparticles based on its parachute effect while crystalline 
CEL did not reach supersaturation. This study demonstrated that electrospraying can be 
used to produce microparticles with tailored properties for pharmaceutical application by 
adjusting solvent selection. 
© 2018 Shenyang Pharmaceutical University. Published by Elsevier B.V. 
This is an open access article under the CC BY-NC-ND license. 
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
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 1. Introduction 
A large fraction of drug compounds under development are
limited by their poor water solubility [1] . Their poor solubil-
ity in aqueous media (including body fluids) often results in a
low and variable oral bioavailability and hence unsatisfactory
therapeutic performance of the drugs [2–4] . There are many
approaches to balance the poor solubility of drugs, where
drug-loaded polymer microparticles continue to be of inter-
est. A solid dispersion system is defined as a mixture of at
least two components, the drug substance and a matrix ex-
cipient [5] , where the drug is highly dispersed in the matrix,
typically in a molecular form increasing the dissolution rate
and bioavailability of the drug from its formulation [6] . Solid
dispersions are particularly favorable for drugs with low gas-
trointestinal solubility but high permeability [7,8] . These are
classified as BCS class II drugs and typically show a correla-
tion between in vitro solubility and in vivo bioavailability [9] . 
The matrix material plays a significant role in solid dis-
persions and influences characteristics such as particle size,
drug devitrification rate, wettability, drug dispersability, and
dissolution behavior [6,10,11] . Hypromellose acetate succinate
(HPMCAS) is a cellulose derived polymer, which is commonly
utilized as an enteric coating agent due to its pH-dependent
solubility in aqueous environments. Moreover, HPMCAS has
demonstrated to be an effective precipitation inhibitor pre-
venting salt recrystallization and prolonging the supersatu-
ration of drugs for several hours after dissolution. The pro-
nounced effect of HPMCAS is explained by the formation
of nanosized amorphous drug-polymer aggregates resulting
from its particle ionized state and from hydrophobic interac-
tions [12,13] . Much indicates that such precipitation inhibition
may provide considerable improvements in the in vivo perfor-
mance of such formulations [14] . 
Currently, two major processes are used in the manufactur-
ing of solid dispersion systems, melting methods and solvent
evaporation methods [8,15] . Many solid dispersion dosage
forms consist of microparticles due to the preparation meth-
ods employed. Their microstructure can have an influence on
the release kinetics, efficacy and the physical stability of the
drug and should thus be optimized to improve the general per-
formance of the formulations [16,17] . 
In this study, electrospraying was used as a method for pro-
ducing microparticulate solid dispersions. Electrospraying is
a liquid atomization technique utilizing a strong electric po-
tential to disrupt the liquid feed into small droplets result-
ing in near-monodisperse microparticles [18,19] . Notably, elec-
trospraying has found potential use in the biomedical field,
where tailored properties of utilized drug delivery vehicles or
diagnostic probes are of significant relevance for therapy and
diagnosis [20,21] . Adjusting the different process parameters
using electrospraying allows for tailored particle engineering.
Yet, the process is complex due to the interplay between dif-
ferent interdependent parameters, which influence the char-
acteristics of the resulting microparticles [22,23] . For instance
the selection of solvent influences both the spray ability of
the liquid feed and the resulting droplet dimensions, based on
characteristics such as surface tension and electric conductiv-
ity, but also influences the particle characteristics, based onthe solubility of materials dissolved or suspended in the sol-
vent [24–26] . 
In the current study, we investigated different solvent
mixtures for preparing a solid dispersion system of HPM-
CAS together with a model drug, CEL, by electrospraying. CEL
is a crystalline, non-steroidal anti-inflammatory drug, and
both its aqueous solubility ( ∼5 μg/ml) and solubility-limited
bioavailability are low [27] . The obtained microparticles were
thoroughly examined by means of X-ray powder diffraction
(XRPD) and scanning electron microscopy (SEM) and the sur-
face drug distribution of the microparticles was determined
using X-ray photoelectron spectroscopy (XPS). Further, the in
vitro drug release and precipitation inhibition was also inves-
tigated for solid dispersions prepared using distinct solvents
and solvent mixtures. 
2. Materials and methods 
2.1. Materials 
The HPMCAS (AQOAT) LF grade was acquired from Shin Etsu
(Tokyo, Japan). CEL powder was purchased from Dr. Reddy
(Hyderabad, India). Acetone (ACE, 99.9% HPLC grade), ethanol
(EtOH, 99.9% HPLC grade) and acetonitrile (99.9% HPLC grade)
were purchased from Sigma Aldrich (Poole, UK). Phosphate-
buffered saline (PBS, 0.01 M, pH 6.8) was prepared from sodium
phosphate monobasic and sodium hydroxide acquired from
Sigma Aldrich. Sodium lauryl sulphate (SLS) was acquired
from Fagron (Waregem, Belgium) and ultrapure water (SG Wa-
ter Purification System, Barsbuttel, Germany) was used for all
experiments. All other chemicals and solvents were of analyt-
ical grade and were used without further purification. 
2.2. Solubility test 
The solubility of HPMCAS and CEL, in ACE, EtOH, water and
mixtures of these solvents was evaluated at room tempera-
ture ( ∼25 °C) by placing 0.5 g of the polymer or drug into 10 ml
of solvent mixture and mixing using a magnetic stirrer. The
degree of dissolution was further assessed visually after 1 and
24 h, and if failing to form a complete solution, the mixture
was diluted with more solvent (10 ml) and if successfully dis-
solved more solute was added [15,28] . The solubility of so-
lutes in the different solvent mixtures was rated according
to a common classification as freely soluble (100–1000 mg/ml),
soluble (33–100 mg/ml) and practically insoluble ( < 0.1 mg/ml)
[29,30] . 
2.3. Preparation of microparticles 
Solutions of HPMCAS and CEL were prepared at a solute con-
centration of 5% (w/v) and a drug loading of 20% (w/w) in dif-
ferent solvents including ACE, ACE –EtOH (85:15, v/v), ACE –H 2 O
(85:15, v/v), EtOH –H 2 O (85:15, v/v). CEL-loaded HPMCAS mi-
croparticles were prepared using a customized single nozzle
electrospraying setup with the same configurations as pre-
viously described [31] . Briefly, the electrospraying setup es-
sentially consisted of a high voltage electrical power source
(Glassman Europe Ltd., Tadley, UK), a precision syringe pump
586 Asian Journal of Pharmaceutical Sciences 13 (2018) 584–591 
Fig. 1 – Jet image captured during electrospraying in 
cone-jet mode. 
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pElite, Harvard Apparatus, Edenbridge, UK), a spraying and 
ollection platform and a custom-built stainless-steel nozzle 
ith an outer and inner diameters of 2.34 and 1.77 mm, re- 
pectively. The feed solutions were electrosprayed at a volt- 
ge of 7–8 kV in the stable cone-jet mode by a feed rate of 
0 μl/min. Microparticles were collected at a distance of 7 cm 
rom the nozzle tip. Only microparticles prepared by a stable 
one-jet ( Fig. 1 ) were collected. All samples were prepared in 
riplicates under room temperature, and stored in a desiccator 
t room temperature. 
.4. XRPD 
he X-ray powder diffraction spectra were detected by a 
W3040/60 X’ Pert Pro MPD (PANalytical, Philips, Netherlands) 
quipped with a copper anode for radiation with λ= 1.542 A˚,
5 kV and 40 mA. The samples were placed on aluminum sam- 
le holders and measured from 5 to 35 ° 2 θ at a step of 0.053 °
nd 0.025 ° per second. 
.5. SEM 
he electrosprayed microparticles were collected on glass 
lides, mounted on stubs with double-sided carbon tape and 
putter-coated with a ∼5 nm layer of gold using a Leica EM 
CE200 (Wetzlar, Germany). Images were acquired using an 
EI/Philips XL30 FEG (Hillsboro, USA) at an acceleration volt- 
ge of 3 kV using the secondary electron detector. The size of 
icroparticles was obtained by averaging the diameter of 200 
icroparticles using the software ImageJ (National Institute 
f Health, Maryland, US). 
.6. XPS 
he surface chemistry of the microparticles was analyzed us- 
ng XPS (Thermo Scientific, Roskilde, Denmark) equipped with 
 monochromated AlKalpha X-ray source. Survey scans of –1350 eV binding energy were performed using a pass en- 
rgy of 200 eV and a step size of 1.0 eV and at a 90 ° take-of
ngle. The surface drug content of the microparticles was de- 
ermined by correlating the ratio of the detected fluorine in 
he samples to the fluorine in CEL alone thereby determining 
he concentration of CEL (in wt %) on the surface of the mi-
roparticles. The atomic concentration (in %) of elements C,
, F, N and S in CEL is 65.4%, 7.7%, 11.5%, 11.5% and 3.9%, re-
pectively. To minimize error, ratios of N/F, S/F and F/C were 
sed to calculate the concentration of CEL at the microparti- 
le surface. 
.7. Drug loading efficiency and HPLC 
he microparticles were dissolved in 1 ml acetonitrile and di- 
uted in 1:10 (v/v) water for determining the concentration of 
EL in the microparticles. The CEL concentration was mea- 
ured by reverse-phase HPLC (Dionex, Germering, Germany) 
oupled with a P680 pump, ASI 100 sample injector, UVD340U 
etector (Dionex, Germering, Germany), and a C18 Kromasil 
26 column (Bohus, Sweden). A mobile phase of acetonitrile- 
 2 O (60:40, v/v) was used at a constant flow rate of 0.5 ml/min
nd samples were injected with a 10 μl injection volume and 
etected at a wavelength of 230 nm. The drug loading effi- 
iency was calculated as: 
rug loading (%) = (Drug mass / Particle mass) ×100 
.8. Drug release study 
rug release from the electrosprayed solid dispersions was 
tudied using a USP paddle Apparatus II. Approximately 
5 mg microparticles were accurately weighted and placed in 
lass vessels fixed in a Sotax AT7 dissolution station (Sotax,
llschwil, Switzerland). Then, 900 ml release medium of phos- 
hate buffered solution (pH 6.8) with or without 1.5% (w/v) SLS 
as added, and constantly stirred by a paddle at a rotation 
ate of 50 rpm at 37 °C. SLS was added to obtain sink condition
or CEL. At each sample point 5 ml release medium was sam- 
led through a 2.7 μm glass microfiber filters (Whatman Ltd.,
xon, England) by a Biolab/Gilson GX-271 auto sampler (Bio- 
ab, Gloucestershire, UK). The vessels were added 5 ml fresh 
elease medium to maintain their volume. Release samples 
ere analyzed by HPLC as outlined above. The release from 
icroparticles was compared with dissolution rate of crys- 
alline CEL powder and the release from the physical mixture 
f HPMCAS and CEL. 
.9. Statistics 
ll experiments were performed in triplicate ( n = 3) except for 
article size measurements where 200 microparticles were 
easured, and the results were indicated by mean value ±SD.
. Results and discussion 
lectrospraying is a one-step processing technique for prepa- 
ation of microparticles, which does not involve elevated tem- 
eratures as with spray-drying [32,33] . In order to prepare 
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Table 1 – Solubility of HPMCAS and CEL, in pure solvents 
and solvent mixtures. Solubility is given as, freely soluble 
( + + ), soluble ( + ) and practically insoluble ( −). 
Solvents HPMCAS CEL 
ACE + + + + 
EtOH – + 
H 2 O – –
ACE –EtOH (85:15) + + + + 
ACE –H 2 O (85:15) + + 
EtOH –H 2 O (85:15) + + 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 – Characteristics of electrosprayed CEL-loaded 
HPMCAS microparticles. 
Solvent Size (μm) Drug entrapment (%) 
ACE 3.4 ± 0.7 96 ±4 
ACE –EtOH (85:15) 3.5 ± 0.7 98 ±3 
ACE –H 2 O (85:15) 3.0 ± 0.6 101 ±3 
EtOH –H 2 O (85:15) 2.7 ± 0.5 97 ±4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 a solid dispersion system with electrospraying using a hy-
drophilic polymeric and poorly water-soluble drug solvent
selection should be considered along with the solubility of
the drug and polymer in the solvent [23,34] . Further, not all
solvents and compounds are compatible with electrospray-
ing, due to constraints with regards to surface tension, vis-
cosity and electrical conductivity [35] . In this study HPM-
CAS and CEL have different solubilities in the distinct sol-
vents, and solvent mixtures were thus investigated to assess
their influence on the characteristics of resulting microparti-
cles and their performance. ACE and three solvent mixtures,
ACE –EtOH, ACE –H 2 O and EtOH –H 2 O, were examined, and were
demonstrated to have an influence on the particle size, parti-
cle morphology, drug distribution and release behavior, which
are presented and discussed below. 
3.1. Solubility of HPMCAS and CEL 
The solubility of HPMCAS and CEL in ACE, EtOH, water and
their mixtures was studied. It was observed that ACE is a good
solvent for both HPMCAS and CEL ( Table 1 ) dissolving up to
200 mg/ml HPMCAS and 600 mg/ml CEL. Adding water or EtOH
to the ACE solution containing HPMCAS and CEL decreased
their solubilities. The same applied for CEL when water was
added to the EtOH solution, whereas in the case of HPMCAS
its solubility increased. CEL is practically insoluble in water
whereas HPMCAS is sparingly soluble in water and EtOH indi-
vidually. For a 50 mg/ml HPMCAS solution with CEL (20%, w/w)
a stable solution was obtained in ACE –H 2 O mixtures up to a
H 2 O content of 50:50 (v/v), whereas for ACE –EtOH mixtures a
stable solution was obtained at even higher EtOH contents. InFig. 2 – XRPD patterns of CEL, HPMCAS and electroEtOH –H 2 O mixtures CEL was soluble up to a H 2 O content of
75:25 (v/v) indicating that in some mixtures the solubility is
limited by HPMCAS whereas in others it is limited by CEL. Fi-
nally, a ratio of 85:15 (v/v) was selected for all three solvent
mixtures (ACE –H 2 O, ACE –EtOH, EtOH –H 2 O) as electrospraying
feed solutions, for which both HPMCAS and CEL could be com-
pletely dissolved. 
Due to the solvent ratio-dependent solubility of HPMCAS
and CEL it was expected to observe differences in particle
formation for microparticles prepared using different solvent
mixtures. Differences in the evaporation rate of the solvents
used, is likely to result in earlier or later precipitation of HPM-
CAS and CEL. For instance, since ACE (b.p. 56 °C) evaporates
quicker than EtOH (b.p. 78 °C) and EtOH evaporates quicker
than H 2 O, the increasing EtOH and H 2 O content in the evap-
orating droplet could result in selective precipitation of HPM-
CAS or CEL. 
3.2. Characterization of microparticles 
XRPD patterns for CEL, HPMCAS and electrosprayed samples
are presented in Fig. 2 and show that while unprocessed CEL
exhibited crystalline features, a halo pattern was observed for
all electrosprayed samples indicating that CEL exists in the
amorphous form in the microparticles. 
The size of electrosprayed CEL-loaded HPMCAS micropar-
ticles from pure ACE and three co-solvent systems are shown
in Table 2 , indicating that all the microparticles were of sim-
ilar size, ranging from 2 to 4 μm in diameter. Microparticles
prepared with ACE and ACE –EtOH were larger than those pre-
pared with ACE –H2O, which were larger than those prepared
with EtOH –H2O. This trend can be explained from the solu-
bility of HPMCAS in the different solvent mixtures, where the
better solvent mixtures resulted in larger microparticles com-sprayed CEL-loaded HPMCAS microparticles. 
588 Asian Journal of Pharmaceutical Sciences 13 (2018) 584–591 
Fig. 3 – Representative SEM images of microparticles prepared with ACE (A, C), ACE-EtOH (B), ACE-H 2 O (D) and EtOH –H 2 O (E, 
F). The scale bars indicate 2 μm. 
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Table 3 – Surface chemical composition of CEL-loaded 
HPMCAS microparticles prepared from the different sol- 
vent systems. 
Solvent N/F S/F F/C CEL concentration (%) 
ACE 0.885 0.308 0.044 22.7 ± 0.3 
ACE –EtOH (85:15) 0.862 0.310 0.050 25.4 ± 1.9 
ACE –H 2 O (85:15) 0.828 0.310 0.060 25.3 ± 2.1 
EtOH –H 2 O (85:15) 1.000 0.364 0.051 19.3 ± 1.5 
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bared with the poorer solvent mixtures [36,37] . Polymer chains 
re more extended in good solvents resulting in a higher vis- 
osity and previous studies have demonstrated that larger mi- 
roparticles are formed due to the higher viscosity and larger 
roplets as well as the lower mobility of the polymer in the 
vaporating droplet [38,39] . Yet, the differences observed in 
article size were modest. 
Nevertheless, the differences in the morphology of mi- 
roparticles prepared with different solvent mixtures were 
ore pronounced ( Fig. 3 ). None of the microparticles prepared 
ere spherical but were instead more disk shaped and flat,
ndicating that the forming microparticles had collapsed dur- 
ng solvent evaporation. The phenomenon is explained by the 
low diffusion of high molecular weight polymer, which can- 
ot follow the evaporation of solvent, thus forming a hol- 
ow structure that later collapses [40] . This is also often ob- 
erved for drying of colloidal suspensions and is known as the 
coffee ring effect” [41] . Microparticles prepared with ACE and 
CE –EtOH showed smooth surfaces, while microparticles pre- 
ared with ACE –H 2 O and EtOH –H 2 O were corrugated with a 
ough surface. The degree of roughness of surface was cor- 
elated with the solubility of HPMCAS in the solvent used 
nd similar observations on surface morphology has been ob- 
erved in previous studies [25,31] . It was also observed that 
he obtained microparticles were not agglomerated during 
torage, assuming that the residual solvent did not affect the 
hysical stability of the microparticles. 
.4. Surface chemistry analysis 
he percentage of CEL on the particle surface was detected 
y atomic concentration of F, N and S atoms, which are not 
resent in the HPMCAS, and is shown in Table 3 . The drug 
oading efficiency indicated that the total amount of drug 
n the microparticles was close to the original concentration 
dded to the feed solution before electrospraying. Surface 
hemistry analysis showed that the surface of CEL-loaded mi- 
roparticles have a CEL concentration between 19% and 25%,ndicating a relatively homogenously distribution of CEL 
ithin the microparticles. Microparticles prepared with 
tOH –H 2 O had the lowest surface CEL concentration. This 
ould be explained by an early precipitation of CEL as the EtOH 
vaporates and the H 2 O concentration increases in the evap- 
rating droplet. Later precipitation of CEL may allow the CEL 
olecules to diffuse out to the particle surface through the 
olymer network. However, differences in surface CEL concen- 
ration were relatively minor. The results are partially in agree- 
ent with the observations from particle size and morphol- 
gy where the solubility of HPMCAS in the solvent mixture in- 
uenced the particle formation, although with the additional 
nfluence of CEL solubility. The process is complex due to the 
alance between polymer precipitation, drug diffusion in the 
olymer matrix, and the evaporation of the two solvents in the 
ixtures. 
.5. Drug release study 
rug release studies demonstrated a substantial improve- 
ent in the dissolution rate of electrosprayed solid disper- 
ions compared with the crystalline CEL powder and the phys- 
cal mixture of CEL and HPMCAS ( Fig. 4 ). Crystalline CEL and
hysical mixture of CEL and HPMCAS both resulted in approx.
% drug release after 4 h, indicating no influence of physically 
lended HPMCAS on CEL dissolution at this small amount. At 
Asian Journal of Pharmaceutical Sciences 13 (2018) 584–591 589 
Fig. 4 – Drug release from electrosprayed microparticles in PBS. Values are presented as the mean ±SD ( n = 3). 
Fig. 5 – Drug release from electrosprayed microparticles in PBS with 1.5% SLS. Values are presented as the mean ±SD ( n = 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 the same time the electrosprayed solid dispersions demon-
strated 45%–65% drug release indicating a 10-fold increase
in dissolution rate. For all electrosprayed samples CEL was
supersaturated and remained supersaturated at approxi-
mately 4 times the equilibrium solubility of CEL for the du-
ration of the dissolution study. 
This indicates that HPMCAS facilitated the dissolution of
CEL and subsequently prevented the recrystallization of CEL
in the dissolution medium by interacting with the dissolved
CEL molecules, as observed in other studies [42,43] . The results
demonstrate that the parachute effect of HPMCAS occurred at
a relatively low concentration of 22 μg/ml. 
All electrosprayed samples reached a drug release of 55%–
60% with slight differences in the dissolution rate between
the samples. Solid dispersions prepared with ACE released the
quickest followed by those prepared in ACE –EtOH, ACE –H 2 O
and EtOH –H 2 O, respectively. This is directly contradictory to
the size and morphology findings where microparticles pre-
pared with ACE and ACE –EtOH were larger with a smooth sur-
face and were therefore expected to result in slower dissolu-
tion than the smaller microparticles with rough surfaces pre-
pared using ACE –H 2 O and EtOH –H 2 O. This could possibly be
explained by differences in the drug distribution where mi-
croparticles prepared with ACE, ACE –EtOH and ACE –H 2 O ex-
hibited a higher surface drug loading compared with those
prepared with EtOH –H 2 O. Although in this study drug release
was only tested in release media with a pH above 6.8, it is
expected that microparticle disintegration and drug releasewould not take place at low pH values below 5.5 due to the
pH dependent solubility of HPMCAS. 
The drug release from electrosprayed solid dispersions
was also studied under sink conditions with addition of SLS
(CEL solubility > 1 mg/ml) ( Fig. 5 ). Here a full dissolution of
the added CEL is observed as expected and only small varia-
tions in the dissolution rate are detected for the different elec-
trosprayed samples. As under non-sink conditions the elec-
trosprayed samples showed a faster drug release compared
with crystalline CEL and the physical mixture of CEL and
HPMCAS. In this case, the physical mixture showed a slightly
faster dissolution rate compared with CEL. The drug release
from electrosprayed samples was again slightly dependent
on the solvent mixture used for preparation and again the
same trend was observed. Microparticles prepared with ACE
had the fastest release while microparticles prepared with
EtOH –H 2 O had the slowest drug release. This suggests that the
microparticles prepared using different solvent mixtures have
differences in drug distribution as well as polymer conforma-
tion, which results in differences in their drug release kinet-
ics. Those with the fastest drug release (ACE, AH 85:15) also
showed higher solubility for both polymer and drug and are
likely to have a finer drug dispersion in the polymer matrix,
resulting in quicker drug dissolution rate. These findings show
that solvent mixtures can be used as a way to vary the solubil-
ity of the solutes in the feed solution and thereby modifying
the characteristics and the drug release from the resulting mi-
croparticles. 
590 Asian Journal of Pharmaceutical Sciences 13 (2018) 584–591 
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[. Conclusion 
PMCAS solid dispersions loaded with CEL were prepared 
y electrospraying using different feasible solvent mixtures 
o investigate if the particle characteristics and drug release 
rofiles were influenced by the solvent composition. All CEL- 
oaded HPMCAS microparticles produced by electrospraying 
ere amorphous and their size and morphology were depen- 
ent on the solubility of HPMCAS in the solvent mixture. All 
icroparticles resulted in rapid release of CEL and maintained 
 supersaturation 4 times higher than the solubility of CEL 
ased on the precipitation inhibition by HPMCAS. Owing to the 
ifferent solubility of CEL and HPMCAS in solvent mixtures,
he electrospraying solvent mixtures influenced the morphol- 
gy, the surface drug distribution and the release profiles of 
icroparticles. The present study highlighted the feasibility to 
nhance the release of poorly water-soluble drug and inhibit 
he recrystallization by using electrosprayed HPMCAS solid 
ispersion, and the possibility to alter the particle character- 
stics by modifying solvent composition. 
onflicts of interest 
he authors report no conflicts of interest associated with this 
anuscript. The authors alone are responsible for the content 
nd writing of this manuscript. 
ubmission declaration 
ll authors have contributed to the conception and design of 
he study and acquisition, analysis and interpretation of data.
ll authors have drafted the article and revised it critically for 
mportant intellectual content. All authors have approved the 
nal article. The authors certify that this manuscript, or any 
art of it, has not been published and will not be submitted 
lsewhere for publication while being considered by the Asian 
ournal of Pharmaceutical Sciences. 
ole of funding source 
he Danish research council provided financial support for 
he conduct of the research. The funding source had no in- 
olvement in the study design; in the collection, analysis and 
nterpretation of data; in the writing of the report; or in the 
ecision to submit the article for publication. 
cknowledgment 
he authors would like to thank the Danish Council for Inde- 
endent Research (Grant No. DFF-12-131927 ) for financial sup- 
ort of this project. 
eferences 
[1] Hauss DJ . Oral lipid-based formulations. Adv Drug Deliv Rev 
2007;59(7):667–76 .[2] Loebmann K , Grohganz H , Laitinen R , Strachan C , Rades T . 
Amino acids as co-amorphous stabilizers for poorly water 
soluble drugs – Part 1: preparation, stability and dissolution 
enhancement. Eur J Pharm Biopharm 2013;85:873–81 .
[3] Savjani KT , Gajjar AK , Savjani JK . Drug solubility: importance 
and enhancement techniques. ISRN Pharm 2012 .
[4] Junyaprasert VB , Morakul B . Nanocrystals for enhancement 
of oral bioavailability of poorly water-soluble drugs. Asian J 
Pharm Sci 2015;10(1):13–23 .
[5] Sekiguchi K , Obi N . Studies on absorption of eutectic 
mixture. I. A comparison of the behavior of eutectic mixture 
of sulfathiazole and that of ordinary sulfathiazole in man. 
Chem Pharm Bull 1961;9(11):866–72 .
[6] Serajuddln ATM . Solid dispersion of poorly water-soluble 
drugs: early promises, subsequent problems, and recent 
breakthroughs. J Pharm Sci 1999;88(10):1058–66 .
[7] Streubel A , Siepmann J , Bodmeier R . Drug delivery to the 
upper small intestine window using gastroretentive 
technologies. Curr Opin Pharmacol 2006;6(5):501–8 .
[8] Vasconcelos T , Sarmento B , Costa P . Solid dispersions as 
strategy to improve oral bioavailability of poor water soluble 
drugs. Drug Discov Today 2007;12(23):1068–75 .
[9] Kawabata Y , Wada K , Nakatani M , Yamada S , Onoue S . 
Formulation design for poorly water-soluble drugs based on 
biopharmaceutics classification system: Basic approaches 
and practical applications. Int J Pharm 2011;420(1):1–10 .
10] Berkland C , King M , Cox A , Kim K , Pack DW . Precise control 
of PLG microsphere size provides enhanced control of drug 
release rate. J Control Release 2002;82(1):137–47 .
11] Klose D , Siepmann F , Elkharraz K , Krenzlin S , Siepmann J . 
How porosity and size affect the drug release mechanisms 
from PLGA-based microparticles. Int J Pharm 
2006;314(2):198–206 .
12] Xua S , Dai WG . Drug precipitation inhibitors in 
supersaturable formulations. Int J Pharm 2013;453(1):36–43 .
13] Curatolo W , Nightingale JA , Herbig SM . Utility of 
hydroxypropylmethylcellulose acetate succinate (HPMCAS) 
for initiation and maintenance of drug supersaturation in 
the GI milieu. Pharm Res 2009;26(6):1419–31 .
14] Friesen DT , Shanker R , Crew M , Smithey DT , Curatolo WJ ,
Nightingale JAS . Hydroxypropyl methylcellulose acetate 
succinate-based spray-dried dispersions: An overview. Mol 
Pharm 2008;5(6):1003–19 .
15] Chiou WL . Pharmaceutical applications of solid dispersion 
systems: X-ray diffraction and aqueous solubility studies on 
griseofulvin-polyethylene glycol 6000 systems. J Pharm Sci 
1977;66(7):989–91 .
16] Won DH , Kim MS , Lee S , Park JS , Hwang SJ . Improved 
physicochemical characteristics of felodipine solid 
dispersion particles by supercritical anti-solvent 
precipitation process. Int J Pharm 2005;301(1–2):199–208 .
17] Paudel A , Worku ZA , Meeus J , Guns S , Van Den Mooter G . 
Manufacturing of solid dispersions of poorly water soluble 
drugs by spray drying: formulation and process 
considerations. Int J Pharm 2013;453(1):253–84 .
18] Bohr A , Kristensen J , Stride E , Dyas M , Edirisinghe M . 
Preparation of microspheres containing low solubility drug 
compound by electrohydrodynamic spraying. Int J Pharm 
2011;412(1–2):59–67 .
19] Jaworek A , Sobczyk AT . Electrospraying route to 
nanotechnology: an overview. J Electrostat 
2008;66(3–4):197–219 .
20] Gao Y , Chang M-W , Ahmad Z , Li J-S . Magnetic-responsive 
microparticles with customized porosity for drug delivery. 
RSC Adv 2016;6(91):88157–67 .
21] Gao Y , Bai Y , Zhao D , Chang M-W , Ahmad Z , Li J-S . Tuning 
microparticle porosity during single needle electrospraying 
synthesis via a non-solvent-based physicochemical 
approach. Polymers 2015;7(12):2701–10 .
Asian Journal of Pharmaceutical Sciences 13 (2018) 584–591 591 
 
 
 
 
 [22] Bohr A , Kristensen J , Dyas M , Edirisinghe M , Stride E . Release 
profile and characteristics of electrosprayed particles for oral
delivery of a practically insoluble drug. J R Soc Interface 
2012;9(75):2437–49 .
[23] Bohr A , Boetker JP , Rades T , Rantanen J , Yang M . Application 
of spray-drying and electrospraying/electospinning for 
poorly water-soluble drugs: a particle engineering approach. 
Curr Pharm Des 2014;20(3):325–48 .
[24] Bock N , Woodruff MA , Hutmacher DW , Dargaville TR . 
Electrospraying, a reproducible method for production of 
polymeric microspheres for biomedical applications. 
Polymers 2011;3(1):131–49 .
[25] Almería B , Deng W , Fahmy TM , Gomez A . Controlling the 
morphology of electrospray-generated PLGA microparticles 
for drug delivery. J Colloid Interface Sci 2010;343(1):125–33 .
[26] Bohr A , Wan F , Kristensen J , Dyas M , Stride E , Baldursdottír S ,
et al. Pharmaceutical microparticle engineering with 
electrospraying: the role of mixed solvent systems in particle
formation and characteristics. J Mater Sci Mater Med 
2015;26(2):61 .
[27] Chawla G , Gupta P , Thilagavathi R , Chakraborti AK ,
Bansal AK . Characterization of solid-state forms of celecoxib.
Eur J Pharm Sci 2003;20(3):305–17 .
[28] Klar F , Urbanetz NA . Solubility parameters of hypromellose 
acetate succinate and plasticization in dry coating 
procedures. Drug Dev Ind Pharm 2016;42(10):1621–35 .
[29] Hansen, Charles M. Hansen solubility parameters: a user’s 
handbook. CRC press 2013: 1689–1699 
[30] European Pharmacopoeia Commission. European directorate
for the quality of medicines & healthcare. European 
Pharmacopoeia. Council of Europe; 2014. p. 2963.
[31] Bohr A , Yang M , Baldursdóttir S , et al. Particle formation and 
characteristics of Celecoxib-loaded poly(lactic-co-glycolic 
acid) microparticles prepared in different solvents using 
electrospraying. Polymer 2012;53(15):3220–9 .
[32] Enayati M , Ahmad Z , Stride E , Edirisinghe M . One-step 
electrohydrodynamic production of drug-loaded micro- and 
nanoparticles. J R Soc Interface 2010;7(45):667–75 .[33] Peltonen L , Valo H , Kolakovic R , Laaksonen T , Hirvonen J . 
Electrospraying, spray drying and related techniques for 
production and formulation of drug nanoparticles. Expert 
Opin Drug Deliv 2010;7(6):705–19 .
[34] Kawakami K , Zhang S , Chauhan RS , et al. Preparation of 
fenofibrate solid dispersion using electrospray deposition 
and improvement in oral absorption by instantaneous 
post-heating of the formulation. Int J Pharm 
2013;450(1–2):123–8 .
[35] Mehta P , Haj-Ahmad R , Rasekh M , et al. Pharmaceutical and 
biomaterial engineering via electrohydrodynamic 
atomization technologies. Drug Discov Today 
2017;22(1):157–65 .
[36] Wan F , Wu JX , Bohr A , et al. Impact of PLGA molecular 
behavior in the feed solution on the drug release kinetics of 
spray dried microparticles. Polymer 2013;54(21):5920–7 .
[37] Tanno F , Nishiyama Y , Kokubo H , Obara S . Evaluation of 
hypromellose acetate succinate (HPMCAS) as a carrier in 
solid dispersions. Drug Dev Ind Pharm 2004;30(1):9–17 .
[38] Yang JT . The viscosity of macromolecules in relation to 
molecular conformation. Adv Protein Chem 1962;16:323–400 .
[39] Debye P , Bueche AM . Intrinsic viscosity, diffusion, and 
sedimentation rate of polymers in solution. J Chem Phys 
1948;16(6):573–9 .
[40] Hong Y , Li Y , Yin Y , Li D , Zou G . Electrohydrodynamic 
atomization of quasi-monodisperse drug-loaded 
spherical/wrinkled microparticles. J Aerosol Sci 
2008;39(6):525–36 .
[41] Nikolov AD , Wasan DT . Mechanisms of the assembly of 
nano-and microparticle two-dimensional structures in a 
wedge film. Ind Eng Chem Res 2008;48(5):2320–6 .
[42] Brouwers J , Brewster ME , Augustijns P . Supersaturating drug 
delivery systems: The answer to solubility-limited oral 
bioavailability? J Pharm Sci 2009;98(8):2549–72 .
[43] Guzmán HR , Tawa M , Zhang Z , et al. Combined use of 
crystalline salt forms and precipitation inhibitors to improve
oral absorption of celecoxib from solid oral formulations. J 
Pharm Sci 2007;96(10):2686–702 .
